Labeling changes for mifepristone.
D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D004348:Drug Labeling / Q000592:standards*; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000139:chemically induced; D018805:Sepsis / Q000139:chemically induced
D000021:Abortifacient Agents, Steroidal; D015735:Mifepristone